| http://dbpedia.org/ontology/abstract
|
Michel Sadelain is an immunologist and gen … Michel Sadelain is an immunologist and genetic engineer at Memorial Sloan Kettering Cancer Center, New York, New York, where he holds the Steve and Barbara Friedman Chair. He is the founding director of the Center for Cell Engineering and the head of the Gene Transfer and Gene Expression Laboratory. He is a member of the department of medicine at Memorial Hospital and of the immunology program at the Sloan Kettering Institute. He is best known for his major contributions to T cell engineering and chimeric antigen receptor (CAR) therapy, an immunotherapy based on the genetic engineering of a patient's own T cells to treat cancer.f a patient's own T cells to treat cancer.
, Мишель Саделайн (Саделейн, Michel Sadelain … Мишель Саделайн (Саделейн, Michel Sadelain; род. 1960) — американский учёный-медик, иммунолог и онколог, пионер иммунотерапии. Доктор медицины (1984), доктор философии (1989), профессор Memorial Sloan Kettering Cancer Center и директор-основатель его Центра клеточной инженерии. Степень доктора медицины получил в Парижском университете в 1984 году, степень доктора философии получил в канадском Альбертском университете в 1989 году. С 1994 года сотрудник Memorial Sloan Kettering Cancer Center. Президент (2015).Член и др. Автор более 150 работ.т (2015).Член и др. Автор более 150 работ.
, Michel J. W. Sadelain (* 1960) ist ein Imm … Michel J. W. Sadelain (* 1960) ist ein Immunologe und Krebsforscher am Memorial Sloan-Kettering Cancer Center. Hier ist er Gründungsdirektor des Center for Cell Engineering und Leiter des Gene Transfer and Gene Expression Laboratory. Sadelain gilt – gemeinsam mit Carl H. June – als Pionier der CAR-T-Zell-Therapie, einer Krebsimmuntherapie. Außerdem arbeitet er zur Stammzelltherapie bei verschiedenen Störungen der Blutbildung. Sadelain erwarb 1984 mit der Arbeit Étude du système antigène-anticorps SSA dans le syndrome de Sjögren et le lupus érythémateux disséminé, relation avec le système SSB einen M.D. an der Universität Pierre und Marie Curie in Paris und 1989 einen Ph.D. an der University of Alberta in Kanada. Als Assistenzarzt arbeitete er am Centre Hospitalier Universitaire Saint-Antoine und als Postdoktorand bei am Massachusetts Institute of Technology (MIT). Seit 1994 arbeitet er am Memorial Sloan-Kettering Cancer Center in New York City. Zusätzlich hat er eine Professur für Innere Medizin am Weill Cornell Medical College inne. Sadelain wurde 2003 zum aktiven Mitglied der American Society for Clinical Investigation gewählt. Er erhielt 2012 den William B. Coley Award des Cancer Research Institute und 2018 sowohl den Passano Award der Passano Foundation als auch den Pasteur-Weizmann/Servier International Prize, 2019 den Gabbay Award und den Prix International de l’INSERM, 2020 den Léopold-Griffuel-Preis.l’INSERM, 2020 den Léopold-Griffuel-Preis.
|
| http://dbpedia.org/ontology/almaMater
|
http://dbpedia.org/resource/University_of_Paris +
, http://dbpedia.org/resource/University_of_Alberta +
|
| http://dbpedia.org/ontology/institution
|
http://dbpedia.org/resource/Memorial_Sloan_Kettering_Cancer_Center +
|
| http://dbpedia.org/ontology/knownFor
|
http://dbpedia.org/resource/Chimeric_antigen_receptor_T_cell +
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Immunologist_Michel_Sadelain.jpg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683970/ +
, https://ashpublications.org/blood/article/118/18/4817/29377/Safety-and-persistence-of-adoptively-transferred +
, https://pubmed.ncbi.nlm.nih.gov/23934177/ +
, https://pubmed.ncbi.nlm.nih.gov/24553386/ +
, https://pubmed.ncbi.nlm.nih.gov/19238016/ +
, https://www.nature.com/articles/35017565 +
, https://www.science.org/doi/10.1126/science.aan4672 +
, https://www.worldcat.org/title/nature-international-weekly-journal-of-science/oclc/1183392911 +
, https://www.science.org/doi/10.1126/scitranslmed.3005930 +
, https://www.the-scientist.com/bio-business/the-car-t-cell-race-35701%7CThe +
, https://www.worldcat.org/title/science-science-translational-medicine/oclc/730088152 +
, https://www.mskcc.org/research/ski/labs/michel-sadelain%7CThe +
, https://www.mskcc.org/videos/2021-asgct-george-stamatoyannopoulos-memorial-lecture%7C2021 +
, https://www.mskcc.org/videos/2021-asgct-outstanding-achievement-award%7C2021 +
, https://pubmed.ncbi.nlm.nih.gov/9705944/ +
, https://www.nature.com/articles/nature21405 +
, https://www.nature.com/articles/nbt.2678 +
, https://www.nature.com/articles/nbt0102-70 +
, https://www.nature.com/articles/nm827 +
, https://www.genengnews.com/topics/drug-discovery/crispr-turbocharges-car-t-cells-boosts-cancer-immunotherapy/%7CCRISPR +
, https://rupress.org/jem/article/188/4/619/7710/Antigen-dependent-CD28-Signaling-Selectively +
, https://doi.org/10.1038/35017565%7Cdoi:10.1038 +
, https://www.nejm.org/doi/full/10.1056/NEJMoa1709919 +
, https://www.technologyreview.com/2015/06/18/167414/biotechs-coming-cancer-cure/%7CBiotech%E2%80%99s +
|
| http://dbpedia.org/ontology/wikiPageID
|
64285983
|
| http://dbpedia.org/ontology/wikiPageLength
|
24306
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1095738688
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Beta_thalassemia +
, http://dbpedia.org/resource/Category:American_immunologists +
, http://dbpedia.org/resource/Single-chain_variable_fragment +
, http://dbpedia.org/resource/Hemoglobinopathies +
, http://dbpedia.org/resource/University_of_Paris +
, http://dbpedia.org/resource/International_Standard_Serial_Number +
, http://dbpedia.org/resource/Digital_object_identifier +
, http://dbpedia.org/resource/Doi:10.1084/jem.188.4.619 +
, http://dbpedia.org/resource/Doi:10.1097/cji.0b013e318194a6e8 +
, http://dbpedia.org/resource/Doi:10.1038/nbt0102-70 +
, http://dbpedia.org/resource/University_of_Alberta +
, http://dbpedia.org/resource/Doi:10.1038/nm827 +
, http://dbpedia.org/resource/Doi:10.1038/nature21405 +
, http://dbpedia.org/resource/Doi:10.1182/blood-2011-04-348540 +
, http://dbpedia.org/resource/National_Institutes_of_Health +
, http://dbpedia.org/resource/Memorial_Sloan_Kettering_Cancer_Center +
, http://dbpedia.org/resource/Massachusetts_Institute_of_Technology +
, http://dbpedia.org/resource/Genetic_engineering +
, http://dbpedia.org/resource/PubMed_Identifier +
, http://dbpedia.org/resource/Category:American_medical_researchers +
, http://dbpedia.org/resource/Chimeric_antigen_receptor_T_cell +
, http://dbpedia.org/resource/Pluripotent_stem_cells +
, http://dbpedia.org/resource/Whitehead_Institute_for_Biomedical_Research +
, http://dbpedia.org/resource/Immunology +
|
| http://dbpedia.org/property/almaMater
|
University of Alberta
, University of Paris
, Massachusetts Institute of Technology
|
| http://dbpedia.org/property/awards
|
2019
, 2020
, 2021
|
| http://dbpedia.org/property/birthPlace
|
France
|
| http://dbpedia.org/property/caption
|
Immunologist Michel Sadelain
|
| http://dbpedia.org/property/knownFor
|
T cell engineering
, chimeric antigen receptor therapy
|
| http://dbpedia.org/property/name
|
Michel Sadelain, MD, PhD
|
| http://dbpedia.org/property/website
|
https://www.mskcc.org/research/ski/labs/michel-sadelain%7CThe +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:PMID +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Infobox_scientist +
|
| http://dbpedia.org/property/workplaces
|
Memorial Sloan Kettering Cancer Center
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:American_medical_researchers +
, http://dbpedia.org/resource/Category:American_immunologists +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Michel_Sadelain?oldid=1095738688&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Immunologist_Michel_Sadelain.jpg +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://www.mskcc.org/research/ski/labs/michel-sadelain%7CThe +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Michel_Sadelain +
|
| http://xmlns.com/foaf/0.1/name
|
Michel Sadelain, MD, PhD
|
| owl:sameAs |
http://dbpedia.org/resource/Michel_Sadelain +
, http://viaf.org/viaf/164956140 +
, https://orcid.org/0000-0002-9031-8025 +
, http://www.wikidata.org/entity/Q50880520 +
, http://ru.dbpedia.org/resource/%D0%A1%D0%B0%D0%B4%D0%B5%D0%BB%D0%B0%D0%B9%D0%BD%2C_%D0%9C%D0%B8%D1%88%D0%B5%D0%BB%D1%8C +
, http://de.dbpedia.org/resource/Michel_Sadelain +
, https://global.dbpedia.org/id/5qCmc +
|
| rdf:type |
http://www.wikidata.org/entity/Q19088 +
, http://dbpedia.org/ontology/Person +
, http://www.wikidata.org/entity/Q215627 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#NaturalPerson +
, http://xmlns.com/foaf/0.1/Person +
, http://www.wikidata.org/entity/Q5 +
, http://www.wikidata.org/entity/Q729 +
, http://www.wikidata.org/entity/Q901 +
, http://dbpedia.org/ontology/Species +
, http://dbpedia.org/ontology/Eukaryote +
, http://dbpedia.org/ontology/Scientist +
, http://schema.org/Person +
, http://dbpedia.org/ontology/Animal +
|
| rdfs:comment |
Michel J. W. Sadelain (* 1960) ist ein Imm … Michel J. W. Sadelain (* 1960) ist ein Immunologe und Krebsforscher am Memorial Sloan-Kettering Cancer Center. Hier ist er Gründungsdirektor des Center for Cell Engineering und Leiter des Gene Transfer and Gene Expression Laboratory. Sadelain gilt – gemeinsam mit Carl H. June – als Pionier der CAR-T-Zell-Therapie, einer Krebsimmuntherapie. Außerdem arbeitet er zur Stammzelltherapie bei verschiedenen Störungen der Blutbildung.i verschiedenen Störungen der Blutbildung.
, Мишель Саделайн (Саделейн, Michel Sadelain … Мишель Саделайн (Саделейн, Michel Sadelain; род. 1960) — американский учёный-медик, иммунолог и онколог, пионер иммунотерапии. Доктор медицины (1984), доктор философии (1989), профессор Memorial Sloan Kettering Cancer Center и директор-основатель его Центра клеточной инженерии. Степень доктора медицины получил в Парижском университете в 1984 году, степень доктора философии получил в канадском Альбертском университете в 1989 году. С 1994 года сотрудник Memorial Sloan Kettering Cancer Center. Президент (2015).Член и др. Автор более 150 работ.т (2015).Член и др. Автор более 150 работ.
, Michel Sadelain is an immunologist and gen … Michel Sadelain is an immunologist and genetic engineer at Memorial Sloan Kettering Cancer Center, New York, New York, where he holds the Steve and Barbara Friedman Chair. He is the founding director of the Center for Cell Engineering and the head of the Gene Transfer and Gene Expression Laboratory. He is a member of the department of medicine at Memorial Hospital and of the immunology program at the Sloan Kettering Institute. He is best known for his major contributions to T cell engineering and chimeric antigen receptor (CAR) therapy, an immunotherapy based on the genetic engineering of a patient's own T cells to treat cancer.f a patient's own T cells to treat cancer.
|
| rdfs:label |
Саделайн, Мишель
, Michel Sadelain
|
